2002
DOI: 10.1210/en.2002-220412
|View full text |Cite
|
Sign up to set email alerts
|

Polyethylene Glycolated Recombinant TNF Receptor I Improves Insulitis and Reduces Incidence of Spontaneous and Cyclophosphamide-Accelerated Diabetes in Nonobese Diabetic Mice

Abstract: We have conducted three studies to examine the role of TNFalpha in islet destruction in female nonobese diabetic mouse (NOD) mice, a model of human autoimmune diabetes, using polyethylene glycolated (PEGylated) soluble TNF receptor type I (PEG sTNF-RI) as TNFalpha antagonist. PEG sTNF-RI (3 mg/kg, sc) was given every other day to NOD mice from age wk 8 for 12 wk (study 1), from age wk 12 for 8 wk (study 2), or from age wk 8 for 3 wk, with cyclophosphamide (6 mg/mouse) injected at wk 9 to accelerate the onset o… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0

Year Published

2004
2004
2016
2016

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 12 publications
(6 citation statements)
references
References 38 publications
0
6
0
Order By: Relevance
“…Induction of the circulating IL-1 receptor antagonist and the soluble TNF␣ p55 receptor demonstrate the well-known anti-inflammatory effects of IL-6 (36). The prophylactic and therapeutic effect of the soluble TNF-␣ receptor type I, as TNF-␣ antagonist, against diabetic insulitis has already been documented in female nonobese diabetic (NOD) mice (37). Moreover, IL-6 is responsible for amelioration of local and systemic inflammation by stimulation of IL-10 production (38).…”
Section: Discussionmentioning
confidence: 99%
“…Induction of the circulating IL-1 receptor antagonist and the soluble TNF␣ p55 receptor demonstrate the well-known anti-inflammatory effects of IL-6 (36). The prophylactic and therapeutic effect of the soluble TNF-␣ receptor type I, as TNF-␣ antagonist, against diabetic insulitis has already been documented in female nonobese diabetic (NOD) mice (37). Moreover, IL-6 is responsible for amelioration of local and systemic inflammation by stimulation of IL-10 production (38).…”
Section: Discussionmentioning
confidence: 99%
“…In addition, Akt has been reported to promote GSK3β phosphorylation and deactivation which indirectly favors LEF-dependent transcription (Gonzalez-Robayna et al, 2000; Fan et al, 2010). The nuclear translocation of NFκB is also promoted by Akt (Wang et al, 2002). …”
Section: Nuclear Events Controlled By Fshmentioning
confidence: 99%
“…The final version may differ from this version. 29 1994;Flodstrom et al, 1999;Holstad and Sandler, 2001;Suarez-Pinzon et al, 2001;Drage et al, 2002;Wang et al, 2002;Thomas et al, 2004).…”
Section: Vgx-1027 Treatment Reduces Clinical Signs Of Mld-stz-inducedmentioning
confidence: 99%